For the Inventor, By the Inventor

Enter assignee name

Grand Cayman, Cayman Islands

Maxygen Holdings Ltd.

USPTO Granted Patents = 19

CIPO Patents = 1

Forward Citations = 277

Loading Chart...

Loading Chart...

16 inventors (with patents filed for the assignee):

Kim Vilbour Andersen (16 out of 47 patents)

Christian Hansen (8 out of 13 patents)

Anne Dam Jensen (7 out of 8 patents)

4. Anders Pedersen (6 out of 20 patents)

5. Torben Lauesgaard Nissen (5 out of 19 patents)

6. Jan Moller Mikkelsen (5 out of 11 patents)

7. Claus Bornaes (4 out of 16 patents)

8. Hans Thalsgaard Schambye (4 out of 5 patents)

9. Bart Van Den Hazel (2 out of 3 patents)

10. Per Ola Freskgaard (2 out of 2 patents)

11. Grethe Norskov Rasmussen (1 out of 25 patents)

12. Carsten Germansen (1 out of 2 patents)

13. Bobby Soni (1 out of 2 patents)

14. Frank Bechnygaard (1 out of 1 patent)

15. Frank Bech Nygaard (1 out of 2 patents)

19 patents: Sort by Forward Citations

1. 7550566 - G-CSF conjugates (2009-06-23),

2. 7550565 - G-CSF conjugates (2009-06-23),

3. 7524931 - Full-length interferon gamma polypeptide variants (2009-04-28),

4. 7504237 - Polynucleotides encoding interferon gamma polypeptides (2009-03-17),

5. 7442524 - Factor VII or VIIa-like molecules (2008-10-28),

6. 7427592 - Factor VII or VIIa - like molecules (2008-09-23),

7. 7419805 - Polynucleotides encoding S99T interferon gamma polypeptide variants and means of expression (2008-09-02),

8. 7414022 - Factor VII or VIIa-like molecules (2008-08-19),

9. 7390638 - S99T C-11 Truncated polynucleotides encoding interferon gamma polypeptide variants (2008-06-24),

10. 7381805 - Compositions comprising mixtures of positional PEG isomers of PEGylated G-CSF (2008-06-03),

11. 7371543 - Factor VII or VIIa-like molecules (2008-05-13),

12. 7232562 - E38N interferon gamma polypeptide variants (2007-06-19),

13. 7230081 - Interferon gamma conjugates (2007-06-12),

14. 7226999 - Protein C or activated protein C-like molecules (2007-06-05),

15. 7038015 - Interferon gamma polypeptide variants (2006-05-02),

Maxygen Holdings Ltd. is a biotechnology company that focuses on the discovery, development, and commercialization of innovative protein-based therapeutic products. With a strong emphasis on genetic engineering and molecular biology, Maxygen is dedicated to addressing unmet medical needs and improving patients' lives. Through extensive research and collaboration with leading experts, Maxygen aims to create breakthrough treatments for various diseases and conditions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

19 Patents

#40 in Grand Cayman

#51 in Cayman Islands

#31,713 in the World

Grand Cayman, Cayman Islands

Maxygen Holdings Ltd.

Forward Citations = 277

16 inventors:

Kim Vilbour Andersen (16 out of 47 patents)

Christian Hansen (8 out of 13 patents)

Anne Dam Jensen (7 out of 8 patents)

4. Anders Pedersen (6 out of 20 patents)

5. Torben Lauesgaard Nissen (5 out of 19 patents)

Please report any incorrect information to support@idiyas.com

Loading…